NCT07004582View on ClinicalTrials.gov

Lab Research Using Mini-tumors to Study Prostate Cancer Treatments

Not yet recruitingOBSERVATIONAL
Enrollment

600

Participants

Timeline

Start Date

October 1, 2025

Primary Completion Date

September 30, 2031

Study Completion Date

December 30, 2031

Conditions
Prostate CancerProstate Cancer Metastatic DiseaseProstate Cancer RecurrentAdvanced Prostate Cancer
Interventions
PROCEDURE

HDR brachytherapy

High dose rate (HDR) brachytherapy for the treatment of high-risk or recurrent prostate cancer

DIAGNOSTIC_TEST

Diagnostic biopsy

Transperineal prostate biopsies guided with transrectal ultrasound for the diagnosis of (recurrent) prostate cancer

Trial Locations (3)

6419 PC

Zuyderland Medisch Centrum, Heerlen

6229 ET

Academisch Ziekenhuis Maastricht, Maastricht

Maastricht Radiation Oncology, Maastricht

All Listed Sponsors
collaborator

Zuyderland Medical Centre

OTHER

collaborator

Maastricht University Medical Center

OTHER

lead

Maastricht Radiation Oncology

OTHER